These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9665041)

  • 1. The effect of recurrence of HCV infection of life after liver transplantation.
    Bona MD; Rupolo G; Ponton P; Iemmolo RM; Boccagni P; Destro C; Ermani M; Naccarato R; Burra P
    Transpl Int; 1998; 11 Suppl 1():S475-9. PubMed ID: 9665041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation.
    De Bona M; Ponton P; Ermani M; Iemmolo RM; Feltrin A; Boccagni P; Gerunda G; Naccarato R; Rupolo G; Burra P
    J Hepatol; 2000 Oct; 33(4):609-15. PubMed ID: 11059865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of hepatitis C recurrence on health-related quality of life in liver transplant recipients.
    Bownik H; Saab S
    Liver Int; 2010 Jan; 30(1):19-30. PubMed ID: 19845850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay.
    Rosen HR; Gretch D; Kaufman E; Quan S
    Am J Gastroenterol; 2000 Aug; 95(8):2035-9. PubMed ID: 10950054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
    Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW
    Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.
    Ghobrial RM; Steadman R; Gornbein J; Lassman C; Holt CD; Chen P; Farmer DG; Yersiz H; Danino N; Collisson E; Baquarizo A; Han SS; Saab S; Goldstein LI; Donovan JA; Esrason K; Busuttil RW
    Ann Surg; 2001 Sep; 234(3):384-93; discussion 393-4. PubMed ID: 11524591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-hepatitis primary disease does not influence 6-year survival after liver transplantation beyond 1 year.
    Caccamo L; Colledan M; Rossi G; Gridelli B; Maggi U; Vannelli A; Damilano I; Lucianetti A; Paone G; Gatti S; Reggiani P; Fassati LR
    Transpl Int; 1998; 11 Suppl 1():S212-20. PubMed ID: 9664982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B virus infection].
    Pei F; Zheng J; Du J; Zhong HH; Yang JP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):408-14. PubMed ID: 18677390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The recurrence of hepatitic C in orthotopic liver transplantation].
    Germi MR; Pellicci R; Testa R; Ardizzone G; Lemut F; Pozzo A; Siani C
    Minerva Anestesiol; 1998; 64(1-2):29-33. PubMed ID: 9658788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing long-term quality of life and depression in German liver transplant recipients: a single-centre cross-sectional study.
    Zahn A; Seubert L; Jünger J; Schellberg D; Weiss KH; Schemmer P; Stremmel W; Sauer P; Gotthardt DN
    Ann Transplant; 2013 Jun; 18():327-35. PubMed ID: 23817439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
    Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: influence of immunosuppressive regimens.
    Hunt J; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
    Liver Transpl; 2001 Dec; 7(12):1056-63. PubMed ID: 11753907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation.
    Ercolani G; Grazi GL; Ravaioli M; Del Gaudio M; Cescon M; Varotti G; Ramacciato G; Vetrone G; Zanello M; Pinna AD
    Liver Transpl; 2006 Jul; 12(7):1104-11. PubMed ID: 16710855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does interferon use prior to liver transplant influence hepatitis C outcomes following transplantation?
    Smallwood GA; Devine R; Fasola C; Stieber AC; Heffron TG
    Transplantation; 2008 Dec; 86(12):1795-8. PubMed ID: 19104424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nonviral factors on hepatitis C recurrence after liver transplantation.
    Cameron AM; Ghobrial RM; Hiatt JR; Carmody IC; Gordon SA; Farmer DG; Yersiz H; Zimmerman MA; Durazo F; Han SH; Saab S; Gornbein J; Busuttil RW
    Ann Surg; 2006 Oct; 244(4):563-71. PubMed ID: 16998365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation.
    Toniutto P; Fabris C; Avellini C; Minisini R; Bitetto D; Rossi E; Smirne C; Pirisi M
    World J Gastroenterol; 2005 Oct; 11(38):5944-50. PubMed ID: 16273604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HCV reinfection after liver transplantation for HCV cirrhosis].
    Pasquale G; Iannicelli P; Martini S; Mogavero AR; Caprio N
    Infez Med; 2005 Dec; 13(4):215-28. PubMed ID: 16388277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.